CC
ISEE

Cannell & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Cannell & Co’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-140,775
Closed -$6.49M – 266
2016
Q3 		$6.49M Buy
140,775
+13,075
+10% +$737K 0.24% 92
2016
Q2 		$6.52M Buy
+127,700
New +$6.35M 0.24% 91

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cannell & Co's ISEE Position: Q4 2016 in Review

Cannell & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2016, closing a stake of 140,775 shares — an estimated $6.49M sold.

Cannell & Co first reported a position in ISEE in Q2 2016 and held it in 2 quarters. The position peaked at $6.52M in Q2 2016. 137 funds tracked by Wall St. Rank hold ISEE as of Q4 2016.

  • Cannell & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Cannell & Co sold 140,775 IVERIC bio, Inc. Common Stock shares in Q4 2016, an estimated $6.49M.
  • Cannell & Co first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • Cannell & Co's IVERIC bio, Inc. Common Stock position peaked at $6.52M in Q2 2016.
  • 137 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2016.

Based on Cannell & Co's 13F filing for Q4 2016, filed 13 Feb 2017.